Trial
NCT03329248
QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
Phase ITERMINATEDSAFETYConfidence: HIGH
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Pancreatic Cancer
Intervention
ALT-803
Why stopped
Study halted prematurely and will not resume; participants are no longer being examined or receiving intervention
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-12